Influenza Vaccination in Adults with Asthma: Safety of an Inactivated Trivalent Influenza Vaccine

References

• Hanania N A, Atmar R L, Castro M. Influenza vaccine in patients with asthma. Expert Rev Vaccines 2006; 5: 111–118
   PubMed Web of Science ®Google Scholar
• Meier C R, Napalkov P N, Wegmuller Y, et al. Population-based study on incidence, risk factors, clinical complications and drug utilisation associated with influenza in the United Kingdom. Eur J Clin Microbiol Infect Dis 2000; 19: 834–842
   PubMed Web of Science ®Google Scholar
• Neuzil K M, Wright P F, Mitchel E F, Jr, Griffin M R. The burden of influenza illness in children with asthma and other chronic medical conditions. J Pediatr 2000; 137: 856–864
   PubMed Web of Science ®Google Scholar
• American Lung Association Asthma Clinical Centers. The safety of inactivated influenza vaccine in adults and children with asthma. N Engl J Med 2001; 345: 1529–1536
   PubMedGoogle Scholar
• Thompson W W, Shay D K, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003; 289: 179–186
   PubMed Web of Science ®Google Scholar
• Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention 2006. 2006, http://www.ginaasthma.org Available at. Accessed December 9
   Google Scholar
• Bell T D, Chai H, Berlow B, Daniels G. Immunization with killed influenza virus in children with chronic asthma. Chest 1978; 73: 140–145
   PubMed Web of Science ®Google Scholar
• Fairchok M P, Trementozzi D P, Carter P S, Regnery H L, Carter E R. Effect of prednisone on response to influenza virus vaccine in asthmatic children. Arch Pediatr Adolesc Med 1998; 152: 1191–1195
   PubMedGoogle Scholar
• National Asthma Education and Prevention Program. Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma. National Heart, Lung, and Blood Institute, Bethesda, MD July, 1997, http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm NIH publication no. 97-4051. Available at. Accessed December 8, 2006
   Google Scholar
• National Health Interview Survey. Receiving influenza vaccine. National Center for Health Statistics, Hyattsville, MD 2000; 22–24, http://www.cdc.gov./nchs/about/major/nhis/nhis2.htm Available at. Accessed October 17, 2001
   Google Scholar
• Nichol K L, Lind A, Margolis K L, et al. The effectiveness of vaccination against influenza in healthy, working adults. N Engl J Med 1995; 333: 889–893
   PubMed Web of Science ®Google Scholar
• van Essen G A, Palache A M, Forleo E, Fedson D S. Influenza vaccination in 2000: recommendations and vaccine use in 50 developed and rapidly developing countries. Vaccine 2003; 21: 1780–1785
   PubMed Web of Science ®Google Scholar
• Williams S G, Schmidt D K, Redd S C, et al. Key clinical activities for quality asthma care: recommendations of the National Asthma Education and Prevention Program. MMWR Recomm Rep 2003; 52: 1–43
   PubMedGoogle Scholar
• Smith N M, Bresee J S, Shay D K, Uyeki T M, Cox N J, Strikas R A. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006; 55: 1–10
   PubMedGoogle Scholar
• Szucs T. The socio-economic burden of influenza. J Antimicrob Chemother 1999; 44: 11–15
   PubMed Web of Science ®Google Scholar
• Verwee B, Auzanneau N, Bondarenko K, Saliou P, Hessel L. Influenza vaccination coverage rates in Italy during the winter of 2002–2003. Abstract W01P-35. Presented at: Options for the Control of Influenza V Conference, OkinawaJapan, October, 7–112003, http://www.eswi.org/W01P_35_Influenza_vaccination_coverage_rates_in_Italy_during_the_winter_of_2002_2003_.cfm Available at. Accessed December 11, 2006
   Google Scholar
• Kroneman M, van Essen G A, John Paget W. Influenza vaccination coverage and reasons to refrain among high-risk persons in four European countries. Vaccine 2006; 24L: 522–628
   Google Scholar
• Ryan J, Zoellner Y, Gradl B, Palache B, Medema J. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries. Vaccine 2006; 24: 6812–6822
   PubMed Web of Science ®Google Scholar
• Szucs T D, Muller D. Influenza vaccination coverage rates in five European countries—a population-based cross-sectional analysis of two consecutive influenza seasons. Vaccine 2005; 23: 5055–5063
   PubMed Web of Science ®Google Scholar
• Wysocki J, Brydak L B. Identifying effective approaches for improving national vaccination coverage: Poland. Presented at: The Second European Influenza Conference, St. Julian's, Malta, September, 11–142005, http://www.evm-vaccines.org/pdfs/malta_presentation_wysocki.pdf Available at. Accessed 8 March 2007
   Google Scholar
• Watson J M, Cordier J F, Nicholson K G. Does influenza immunisation cause exacerbations of chronic airflow obstruction or asthma?. Thorax 1997; 52: 190–194
   PubMed Web of Science ®Google Scholar
• Park C L, Frank A L, Sullivan M, Jindal P, Baxter B D. Influenza vaccination of children during acute asthma exacerbation and concurrent prednisone therapy. Pediatrics 1996; 98: 196–200, (pt 1)
   PubMed Web of Science ®Google Scholar
• Park C L, Frank A. Does influenza vaccination exacerbate asthma?. Drug Saf 1998; 19: 83–88
   PubMed Web of Science ®Google Scholar
• Hassan W U, Henderson A F, Keany N P. Influenza vaccination in asthma. Lancet 1992; 339: 194
   PubMedGoogle Scholar
• Daggett P. Influenza and asthma. Lancet 1992; 339: 367
   PubMedGoogle Scholar
• Christy C, Aligne C A, Auinger P, Pulcino T, Weitzman M. Effectiveness of influenza vaccine for the prevention of asthma exacerbations. Arch Dis Child 2004; 89: 734–735
   PubMed Web of Science ®Google Scholar
• Albazzaz M K, Harvey J E, Grilli E A, Caul E O, Roome A P. Subunit influenza vaccination in adults with asthma: effect on clinical state, airway reactivity, and antibody response. Br Med J 1987; 294: 1196–1197
   PubMed Web of Science ®Google Scholar
• Banks J, Bevan C, Fennerty A, Ebden P, Walters E H, Smith A P. Association between rise in antibodies and increase in airway sensitivity after intramuscular injection of killed influenza virus in asthmatic patients. Eur J Respir Dis 1985; 66: 68–272
   Google Scholar
• de Jongste J C, Degenhart H J, Neijens H J, Duiverman E J, Raatgeep H C, Kerrebijn K F. Bronchial responsiveness and leucocyte reactivity after influenza vaccine in asthmatic patients. Eur J Respir Dis 1984; 65: 196–200
   PubMedGoogle Scholar
• Ghirga G, Ghirga P, Rodino P, Presti A. Safety of the subunit influenza vaccine in asthmatic children. Vaccine 1991; 9: 913–914
   PubMed Web of Science ®Google Scholar
• Kramarz P, DeStefano F, Gargiullo P M, Davis R L, Chen R T, Mullooly J P, et al. Does influenza vaccination exacerbate asthma? Analysis of a large cohort of children with asthma. Arch Fam Med 2000; 9: 617–623
   PubMedGoogle Scholar
• Kava T, Lindqvist A, Karjalainen J, Laitinen L A. Unchanged bronchial reactivity after killed influenza virus vaccine in adult asthmatics. Respiration 1987; 51: 98–104
   PubMedGoogle Scholar
• Nicholson K G, Nguyen-Van-Tam J S, Ahmed A H, et al. Randomised placebo-controlled crossover trial on effect of inactivated influenza vaccine on pulmonary function in asthma. Lancet Jan 31, 1998; 351(9099)326–331
   PubMedGoogle Scholar
• Stenius-Aarniala B, Huttunen J K, Pyhala R, et al. Lack of clinical exacerbations in adults with chronic asthma after immunization with killed influenza virus. Chest 1986; 89: 786–789
   PubMed Web of Science ®Google Scholar
• Miller R L, Cheng M, Di Mango E A, Geromanos K, Rothman P B, the American Lung Association Asthma Clinical Research Centers. T-cell responses and hypersensitivity to influenza and egg antigens among adults with asthma immunized with the influenza vaccine. J Allergy Clin Immunol 2003; 112: 606–608
   PubMed Web of Science ®Google Scholar